Certara reposted this
At last week's Bloomberg's AI and Drug Development Forum, Parexel’s Stephen Pyke joined Bloomberg’s VaNae N. Hamilton, Ph.D. and Certara’s Christopher Bouton, Ph.D. for a panel discussion on AI and the Approval/Post-Approval Process. Together they weighed in on the integration of AI into drug development: ✔ What applications already use AI or machine learning elements ✔ Where we need more regulatory guidance ✔ The future of AI-derived biomarker applications and other innovations 💬 Question for our followers: What area of clinical development do you think could benefit most from AI integration, and why? Comment below with your perspective! #AI #DrugDevelopment #Bloomberg
